Pharmaceutical giant GlaxoSmithKline has announced an initiative designed to improve the health of employees with diabetes. Yes, the company's head honchos decided they would take the bull by the horns: if employees have difficulty taking care of their health, they determined to find out why and correct the problem. Result: an internal analysis of healthcare spending within GSK.

Turns out diabetes was one of the biggest problems for Glaxo employees. Glaxo's number-crunchers found the company spends more on diabetes medications, but less on medical care, than the national average. GSK's report states the company spent a total of $26.2 million on diabetes treatment for employees in 2005. Glaxo has now launched what it describes as a multilateral plan to address the needs of employees with diabetes. Leading the charge: a patient education campaign ("Know Your Numbers") and a physician intervention program.

Says Glaxo's US benefits chief, Michael Killian, "As a nation, we are seeing our healthcare costs soar and patients' health decline due to chronic diseases such as diabetes. GSK faces these same challenges and is prepared to meet them." Translation: prevention, prevention, prevention.

Glaxo figures there is nothing to lose, but lots to gain. Healthcare plans for employees already cost a bundle. By targeting the health issues that are hurting employees the most, the company can give those employees a better life and save a lotta money. In addition to making the results of its internal analysis available to the general public, Glaxo has invited other employers to utilize this same approach.

If you've been around the diabetes online community you've certainly heard of Amy Tenderich. Her award-winning site is touted as one of the most influential diabetes sites out there. If you're looking for a gold mine of straight talk and encouragement -- Diabetes Mine is your destination. And now is your chance to speak to the celebrity herself! Amy will be chatting live on Tuesday, May 22, 9pm EST on Diabetes Talkfest.

Her charm comes through, loud and clear, in her cynically optimistic view of the trials of living with diabetes. Her journalistic flair derives from the heart and covers topics like breaking news and inside looks at diabetes research, as well as daily life with diabetes and uncovering the diabetics' deepest hopes and fears. Her all inclusive panache, along with her comedic nuances, make every moment of reading worth it.

Diabetes Mine has been featured in the Wall St. Journal, the UK Guardian, TechCrunch, NPR's Future Tense, and a number of other publications. The most recent feather in Amy's cap was added when she collaborated with Dr. Richard Jackson, a leading physician from Joslin Diabetes Center, to co-author the book Know Your Numbers, Outlive Your Diabetes. True to form, the book is hailed as the first-ever straightforward guidebook providing a clear strategy for living well with diabetes and avoiding the long-term health damage it can cause. I look forward to the opportunity of chatting with Amy. Hope you all can join us!